Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Peter F. Thadeio"'
Autor:
Mark R. Cullen, Adina R. Lemeshow, Sandra Amaro, Elisa V. Bandera, Lisa A. Cooper, Ichiro Kawachi, Joseph Lunyera, Laura McKinley, Christopher S. Poss, Melinda M. Rottas, Stephen E. Schachterle, Peter F. Thadeio, Leo J. Russo
Publikováno v:
Contemporary Clinical Trials. 129:107184
Autor:
Raven Houck, David Gruben, David Scholfield, Peter F. Thadeio, Kannan Natarajan, Patrick J. McCann, Rob Goodwin, Brian Corrigan, Rod MacKenzie, Annette Schettino, Marie-Pierre Hellio, Melinda D. Rottas, Judy Sewards, Peter Honig, David Keller, Koshika Soma, Rachel Simons
Publikováno v:
Contemporary clinical trials. 106
The approval of new medicinal agents requires robust efficacy and safety clinical trial data demonstrated to be applicable to population subgroups. Limited data have previously been reported by drug sponsors on the topic of clinical trial diversity.
Publikováno v:
Nature Chemical Biology. 1:389-397
The high failure rate of experimental medicines in clinical trials accentuates inefficiencies of current drug discovery processes caused by a lack of tools for translating the information exchange between protein and organ system networks. Recently,
Publikováno v:
Proceedings of the National Academy of Sciences. 102:261-266
Establishing quantitative relationships between molecular structure and broad biological effects has been a longstanding challenge in science. Currently, no method exists for forecasting broad biological activity profiles of medicinal agents even wit
Autor:
Nicholas A. Saccomano, W S Faraci, Peter F. Thadeio, Steven D. Heck, Robert A. Volkmann, P R Kelbaugh
Publikováno v:
Proceedings of the National Academy of Sciences. 93:4036-4039
Since ribosomally mediated protein biosynthesis is confined to the L-amino acid pool, the presence of D-amino acids in peptides was considered for many years to be restricted to proteins of prokaryotic origin. Unicellular microorganisms have been res
Autor:
Justin G. Stroh, Nicholas A. Saccomano, Paul R. Kelbaugh, Heck Steven D, Robert A. Volkmann, Kelly Mary E, Peter F. Thadeio
Publikováno v:
Journal of the American Chemical Society. 116:10426-10436
Publikováno v:
Tetrahedron Letters. 34:5831-5834
The synthesis of racemic CP-99,994, a highly potent substance P antagonist is reported. The synthesis outlined here is suitable for developing structure activity relationships for this important class of compounds.
Autor:
Lorraine A. Lebel, Morgan Meltz, Fredric J. Vinick, Stanley Jung, Nicholas A. Saccomano, Ian H. Williams, Lorena L. Russo, D. Helweg, J. A. Nielsen, B. K. Koe, J. L. Jun. Johnson, Peter F. Thadeio
Publikováno v:
ChemInform. 22
Autor:
Robin W. Spencer, Ian H. Williams, Christopher A. Lipinski, Manoj C. Desai, Dane R. Liston, Peter F. Thadeio
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 1:411-414
Two positions on the acetylcholinesterase (AChE) inhibitor, 9-amino-1,2,3,4-tetrahydroacridine (THA), have been identified which can be modified to vary log P, log D and pKa values. Most importantly, these changes can be carried out without altering
Autor:
Robert D. Williams, Robert A. Volkmann, Thomas N. Parks, Kelly Mary E, Nicholas A. Saccomano, Chester J. Siok, Steven D. Heck, William R. Gray, Peter F. Thadeio, Karen J. Krapcho, Hunter Jackson, Michael K. Ahlijanian, Alan H. Ganong, Melissa J. Welch, Paul R. Kelbaugh, Anthony J. Lanzetti, Phillips Douglas
Publikováno v:
Science (New York, N.Y.). 266(5187)
The venom of the funnel-web spider Agelenopsis aperta contains several peptides that paralyze prey by blocking voltage-sensitive calcium channels. Two peptides, omega-Aga-IVB (IVB) and omega-Aga-IVC (IVC), have identical amino acid sequences, yet hav